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Purpose or Objective: In the field of Adaptive Radiation 
Therapy (ART), non-linear transformation models should be 
considered to take into account complex motion and 
anatomic variations. In order to follow and then predict 
intra-organ dynamic, a novel voxel-by-voxel approach has 
been proposed using epidemic model. The susceptible-
infected-susceptible (SIS) model was applied to radiotherapy 
treatments to predict morphological variations in the Head 
and Neck (H&N) region and to follow single voxel motion and 
warping. 
 
Material and Methods: 360 daily MVCT studies of 12 H&N 
patients treated by Tomotherapy® were retrospectively 
analyzed. Deformable image registration (DIR) and automatic 
structures re-contouring were performed by RayStation® 
treatment planning system (TPS). The study focused on 
parotid glands (PG) identified by previously studies such as 
organs systematically affected by warping. Using the 
epidemic model, PG shrinkage was evaluated considering 
each voxel as a single subject and the deformed vector field 
(DVF) as an infection. A dedicated IronPython® script was 
developed to export daily coordinates and DVF displacements 
from the deformed mesh grid obtained by the TPS for each 
vertex of the region of interest (ROI) contouring. Finally, the 
SIS model was developed by a MATLAB® home-made 
simulation tool.  
 
Results: The patients’ validation was obtained by splitting 
susceptible (S) and infectious (I) cases; 0.4cm of voxel 
displacement was set as clinical threshold within a [0÷1cm] 
range of warping. Correlation between epidemic model and 
daily PG shrinkage was carried out by dynamic time warping 
(DTW) algorithm applied to the SIS parameters. A DTW 
distance of 2.39±0.66 was obtained setting the contact rate 
at 7.55±0.69 and the recovery rate at 2.45±0.26; birth rate 
was not counted in a constant population hypothesis. A 
physician’s multiple-blind evaluation confirmed that PG 
warping evolution could be predicted, applying the SIS 




Conclusion: Combining epidemic model with ART and image 
systems can on-line support and validate daily setup and 
assess anatomical warping. In this novel approach, 
contrariwise to a time series analysis of the whole organ, 
specific and localized intra-organ variation could be 
detected. Moreover, integrating a dose accumulation 
evaluation, the SIS model could aid clinic decision making to 
suggest possible re-planning during the 6 weeks of therapy. A 
3D model of the ROI can be generated and its evolution 
during the treatment course can be investigated. 
 
EP-1807  
Replanning effects in Tomotherapy treatment using dose 
accumulation and dose deformation strategies 
A. Ciarmatori
1Azienda Ospedaliero Universitaria di Modena, Medical 
Physics Department, Modena, Italy 
1,2, G. Gabriele1, N. Maffei1,3, C. Vecchi3, M.G. 
Mistretta1, P. Ceroni1, B. Meduri4, P. Giacobazzi4, T. Costi1 
2University of Bologna, Post Graduate School in Medical 
Physics, Bologna, Italy 
3University of Bologna, Physics Department, Bologna, Italy 
4Azienda Ospedaliero Universitaria di Modena, Radiation 
Oncology Department, Modena, Italy 
 
Purpose or Objective: Quantification of the delivered dose is 
one of the most important feature in inter-patient variability 
in radiation treatment. Difference between planned and 
accumulated doses contains different uncertainties due to 
set-up errors, patient movement and anatomy variations. 
Shrinkage of Parotid Glands (PG) in Head and Neck (H&N) 
patients is a major issue in accumulation of the delivered 
dose. This study investigates Target and Organs at Risks 
(OARs) variations during the treatment course and their 
dosimetric consequences. We evaluated the effect of 
replanning on the deformed structure during the course of 
treatment. 
 
Material and Methods: Six patients with H&N cancer treated 
by Tomotherapy (SIB 66 Gy, 60 Gy, 54 Gy in 30 Daily 
Fractions) have been, retrospectively, enrolled. Through 
Planned Adaptive® software each delivered fraction have 
been recalculated on daily imaging to obtain the daily dose 
(DMVCT). Deformable image registration (DIR), using 
Raystation (v.4.7.2), have been performed to propagate the 
structures along the treatment course. The planned doses 
were mapped (DDVF) using the deformed vector field (DVF) 
matrix. The DVF obtained from the reverse DIR was used to 
deform DMVCT to match the planning kVCT; we obtain a 
voxel by voxel association of DMVCT in a single image 
dataset. DDVF and DMVCT were compared performing 3D-γ 
analysis (2 mm, 2%) to evaluate the agreement on 3D 
distribution and warped structures. Two replanning strategies 
were adopted during the 18th fractions: (1) re-plan on 
original target and deformed OARs (D18,OAR) and (2) re-plan 
on deformed target and deformed OARs (D18).  
 
Results: DDVF and DMVCT did not show a good consistency 
(3D γ-passing rate = 85 ± 1 %, p<0.001). DDVF was 
significantly (p<0.01) lower than DMVCT in term of average 
doses in PG (12.2 ± 10.3 %). Smaller differences were 
founded in average doses to the PTVs (2.6 ± 2.1 %). γ-passing 
rate and dosimetric variation to PG and PTVs did not show 
relevant correlation (p>0.05). Parotid gland showed a 
systematic shrinking during the course of treatment 
quantifiable in about 4% volume reduction for week of 
treatment. Full accumulation of dose showed an increase of 
the average dose to PG of 3.0 Gy ± 3.3 Gy [-4.6 Gy ÷ 7.7 Gy]. 
PTV volume variations were negligible (4.7 ± 1.6 %). The 
average doses of the PTVs increase of 1.6 Gy ± 1.3 Gy [-0.5 
Gy ÷ 3.4 Gy]. Retrospective re-planning analysis showed that 
5 out of 6 (83 %) patients enrolled could had benefit from 
ART. By ART the PG average dose decreased -2.0 Gy ± 1.4 Gy 
[-3.8 Gy ÷ -0.2 Gy] in first replanning strategy (D18,OAR) and 
-3.2 Gy ± 1.7 Gy [-5.0 Gy ÷ -0.2 Gy] in case of both Target 








Conclusion: DDVF do not describe adequately the delivered 
dose in the patient. Difference between planned and 
delivered doses in PTVs is reasonable, conversely anatomical 
variations seems to be a cause of overdosage in PG. Re-
planning on 18Th MVCT could brought significant benefits, in 
terms average dose of PG. 
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Purpose or Objective: Several adaptive strategies have been 
implemented to account for anatomical changes during 
radiotherapy for bladder cancer. To obtain target structures, 
either the first four CBCT scans can be used (CBCT-based 
strategy), or the interpolation of bladder volumes on 
pretreatment CT scans (CT-based strategy). The purpose of 
this study was to determine whether the CBCT-based or CT-
based strategy is more favorable in terms of tumor control 
probability (TCP) and normal tissue sparing. 
 
Material and Methods: Ten patients from each of the two 
participating institutes were analyzed, adopting the clinically 
used adaptive strategy and dose prescription from each 
institute. With the CBCT-based strategy, a library of three 
plans was created, corresponding to a small, medium and 
large bladder. Patients received 70 Gy to the bladder tumor, 
60 Gy to the non-involved bladder and 48 Gy to the lymph 
nodes, in 30-35 fractions. With the CT-based strategy, a 
library of five plans was created using two pre-treatment CT 
scans, with full and empty bladder, respectively. Patients 
received 55 Gy to the tumor and 40 Gy to bladder and lymph 
nodes, in 20 fractions.  
Tumor control: TCP was calculated for the combined target 
volumes of tumor and bladder, using the Linear-Quadratic 
model with an α/β ratio of 13 Gy. Since tumor cell density in 
the non-involved bladder wall was unknown, it was varied 
between 10^2 and 10^7 cells/cm³. To investigate the effect 
of the different dose prescriptions, the TCP was recalculated 
for the CT-based strategy with the dose scaled to 70 Gy in 35 
fractions.  
Normal tissue sparing: for rectum and bowel cavity, the 
equivalent dose in 2 Gy fractions (EQD2) was calculated using 
α/β values of 5 and 8 Gy, respectively, and DVH parameters 
were extracted. In addition, the planning target volume for 
each chosen plan divided by the daily bladder volume was 
calculated. Differences in parameters between groups were 
assessed using a Wilcoxon signed-rank test.  
 
Results: A higher TCP for the CBCT-based strategy compared 
to the CT-based strategy was found, independent of modeled 
cell density in the non-involved bladder wall (Figure 1). For a 
low cell density, median TCP for the CBCT-based strategy 
was 75%, compared to 49% for the CT-based strategy. These 
results were comparable to 3-year local control rates 
previously reported. In addition, scaling the dose from the 
CT-based strategy to 70 Gy increased the median TCP to 72%. 
For the CT-based strategy, a lower median rectum V30Gy and 
lower median bowel V45Gy compared to the CBCT-based 
strategy were observed (Figure 1). This difference is 
reflected in the finding that the PTV is on average 3.9 times 
larger than the daily bladder volume for the CBCT-strategy, 




Conclusion: Total bladder TCP is higher for the CBCT-based 
strategy, which is due to prescription differences. The 
adaptive strategy based on CT scans results in the lowest 
rectum V30Gy (EQD2) and bowel cavity V45Gy (EQD2). 
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Purpose or Objective: To investigate the patient's movement 
during the preparation of an adaptive cranial radiosurgery 
(SRS) procedure and its dosimetric impact. 
 
